Stockscreener 앱 받기
3.14
33.05%
0.78
시간 외 거래:
3.10
-0.04
-1.27%
전일 마감가:
$2.36
열려 있는:
$2.39
하루 거래량:
785.30K
Relative Volume:
7.30
시가총액:
$6.84M
수익:
$3.58M
순이익/손실:
$-11.33M
주가수익비율:
-0.2863
EPS:
-10.9665
순현금흐름:
$-9.75M
1주 성능:
+25.60%
1개월 성능:
+27.64%
6개월 성능:
-61.09%
1년 성능:
-74.05%
1일 변동 폭
$2.3626
$3.60
1주일 범위
$2.27
$3.60
52주 변동 폭
$2.27
$24.90
Intelligent Bio Solutions Inc Stock (INBS) Company Profile
명칭
Intelligent Bio Solutions Inc
전화
646-790-5756
주소
135 W 41ST ST,, NEW YORK
Compare INBS vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INBS
Intelligent Bio Solutions Inc
|
3.14 | 5.14M | 3.58M | -11.33M | -9.75M | -10.97 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Intelligent Bio Solutions Inc 주식(INBS)의 최신 뉴스
Intelligent Bio Solutions Inc (STU:12Q0) Stock Price & 30 Year Financial Data - GuruFocus
How Intelligent (INBS) is reshaping its industry (Trend Weakens) 2026-05-08Gap Down Stocks - newser.com
INBS Stock Price, Quote & Chart | INTELLIGENT BIO SOLUTIONS IN (NASDAQ:INBS) - ChartMill
The moat Intelligent (INBS) is building for long term dominance (Breakdown Watch) 2026-05-05Top Breakouts - newser.com
Intelligent Bio Solutions expects 16% year over year growth in fourth quarter revenue - MSN
Is Intelligent (INBS) stock near resistance (-4.79%) 2026-04-22Verified Stock Signals - Cổng thông tin điện tử tỉnh Lào Cai
Intelligent Bio Solutions Updates Investor Presentation and Share Count - The Globe and Mail
Intelligent Bio : Investor DeckApril 2026 - marketscreener.com
Intelligent Bio Solutions (INBS) Launches Study to Enhance Drug Screening Speed - GuruFocus
Intelligent Bio Solutions Inc. Launches Validation Study to Achieve Sub-3-Minute Results in Roadside Drug Testing Technology - Quiver Quantitative
Fingerprint drug test aims for under-3-minute roadside results - Stock Titan
Intelligent Bio Solutions (NASDAQ: INBS) posts new investor deck and share update - Stock Titan
Is Intelligent (INBS) stock undervalued compared to peers (Extends Gains) 2026-04-20Theta Decay - Cổng thông tin điện tử tỉnh Lào Cai
INBS completes penetration testing for FDA 510(k) submission By Investing.com - Investing.com India
Intelligent Bio Solutions (INBS) Enhances Security Ahead of FDA Submission - GuruFocus
Intelligent Bio Solutions Inc. Advances Fda 510(K) Submission And Completes Penetration Testing - marketscreener.com
INBS completes penetration testing for FDA 510(k) submission - Investing.com
Intelligent Bio Solutions Advances Upcoming FDA 510(k) Submission, Successfully Completes Penetration Testing with No Major Vulnerabilities Identified - The Manila Times
No major security flaws found as Intelligent Bio readies FDA filing - Stock Titan
Is Intelligent (INBS) Stock Slowing Down | Price at $2.56, Up 4.07%Social Trade Signals - newser.com
How cyclical is Intelligent Bio Solutions Incs revenue stream2026 Price Swings & Smart Money Movement Tracker - baoquankhu1.vn
Is Intelligent (INBS) Stock Underperforming | Price at $2.77, Up 0.91%Community Exit Signals - newser.com
INBS Advances FDA Approval with Successful Initial Study - GuruFocus
Intelligent Bio Solutions Completes Clinical Cut-off Study, Advances FDA 510(k) Clinical Program Targeting Multi-Billion-Dollar U.S. Drug Screening Market - Bitget
Intelligent Bio Solutions Completes Clinical Cut-Off Study - TradingView — Track All Markets
INBS Stock Falls After Clinical Study Win: FDA Progress Fails To Lift Shares - Stocktwits
A fingerprint drug test moved closer to a U.S. launch after codeine study - Stock Titan
Published on: 2026-03-31 09:14:37 - baoquankhu1.vn
Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant - Bitget
Intelligent Bio Solutions receives European patent for drug testing tech - Investing.com
Intelligent Bio Solutions receives European patent for drug testing tech By Investing.com - Investing.com India
A fingerprint sweat drug test just won its 8th European patent - stocktitan.net
Intelligent Bio Solutions Inc. Announces 2026 Restricted Stock Award Agreements and Incentive Plan Updates - Minichart
Intelligent Bio Solutions Grants Equity Awards, Updates ATM Capacity - TipRanks
Intelligent Bio Solutions grants equity to CEO Harry Simeonidis and CFO Spiro Sakiris - TradingView
Intelligent Bio Solutions (NASDAQ: INBS) details new equity awards, ATM capacity - Stock Titan
INBS (NASDAQ: INBS) files ATM with Ladenburg to raise up to $3.97M - Stock Titan
If You Invested $1,000 in Intelligent Bio Solutions Inc (INBS) - Stock Titan
INBS (INBS) director receives 5,000 restricted shares in equity award - stocktitan.net
Intelligent Bio Solutions (NASDAQ: INBS) grants director 5,000 restricted shares - Stock Titan
INBS (INBS) CFO receives time- and performance-based restricted stock grants - Stock Titan
Director at Intelligent Bio Solutions (INBS) granted 5,000 shares - Stock Titan
Director at Intelligent Bio Solutions (INBS) awarded 5,000 restricted shares - Stock Titan
INBS (INBS) CEO receives time- and performance-based restricted stock grants - Stock Titan
Intelligent Bio Solutions Inc.: Fundamental Analysis and Financial Ratings | 12Q | US36151G7097 - marketscreener.com
Aug Setups: Is Intelligent Bio Solutions Inc part of any major index2026 Trends & Weekly Breakout Watchlists - baoquankhu1.vn
Why Is INBS Stock Rising Today? - Dailyhunt
Intelligent Bio Solutions Inc (INBS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.34%
자본화:
|
볼륨(24시간):